RCIGM Founder Stephen Kingsmore will present on "NICU Current State & Future of Whole Genome Sequencing" and receive a Luminary Award.

Speaker: Stephen Kingsmore, MD, DSc | President & CEO, Rady Children’s Institute for Genomic Medicine

RCIGM President & CEO Stephen Kingsmore will speak on a panel about newborn screening via rWGS.

Speaker: Charlotte Hobbs, MD, PhD | Chief Research and Clinical Management Officer, Rady Children’s Institute for Genomic Medicine

With the advances in genomic sequencing and its impact on the care we provide for our critically ill neonates in our intensive care units, there has been an increasing need for us to become as informed as possible with the lingo and implications. Please join us to discuss “Using Genomics Wisely” and the Ethical, Legal, and Social Issues surrounding personalized medicine. Faculty: Nathaly M. Sweeney, MD, MPH; John Zupancic, MD, MS, ScD; Ingrid Holm, MD, MPH; Russell Nofsinger, PhD; Jeffrey Horbar, MD

As part of the Newborn Screening workshop (8am-12pm), Dr. Kingsmore will present "Newborn Screening: Toward a System that Keeps Pace with Gene Therapy Advances" from 11:05-11:15am.

Dr. Stephen Kingsmore and Tiledb founder and CEO Stavros Papadopoulos will present "Scaling Newborn Screening & Precision Medicine to 1 Million Babies" at this luncheon presentation.

Dr. Nathaly Sweeney from RCIGM/RCHSD will present as part of the NYU Center for Human Genetics and Genomics' Genetic Medicine Colloquium

RCIGM President & CEO Stephen Kingsmore will co-present a keynote panel with Tom Defay, Deputy Head of Diagnostics Strategy and Development at Alexion Pharmaceuticals, titled "Towards Newborn Screening by Whole Genome Sequencing."